ClinicalTrials.gg
RecruitingNCT06507670Updated Jun 3, 2026

Point of Care Ultrasound for the Detection of Esophageal Food Bolus

An observational study in Esophageal Foreign Body and Esophageal Obstruction, sponsored by WellSpan Health. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-03.

Sponsored by WellSpan Health · Observational

How we know

From the registry’s dates

  • Started Jul 2024; still recruiting 2 years 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
30
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 40 studies in Airway Obstruction with a site in United States — 8 open to participants now, 9 under way, none of them phase 3. Airway Obstruction · United States.

Planned enrollment
11th of 11
30 · median 168
Started
2024
with 3 others
Observational
11 of 40
2 open now
Registered
35th of 40
by date

Among the 40 studies in Airway Obstruction with a site in United States, this one is the 11th largest by planned enrollment of the 11 observational ones that give a count, is one of 4 that started in 2024, is one of 11 observational ones, and was the 35th registered.

Airway Obstruction

148 studies on the registry are indexed under Airway Obstruction; 26 are open to participants now.

Browse Airway Obstruction studies →

Open to participants now

8 of the 40 studies in Airway Obstruction with a site in United States are open now. Recruiting first, the newest first:

2 more — sign in →

All 8 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 20 Airway Obstruction studies recruiting now, 13 (65%) set no upper age limit and 5 (25%) stop at 75 or younger; 3 take children under 18; 5 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 40 studies in Airway Obstruction with a site in United States, or all of them as a file.
02

Study summary

This will be a prospective, observational, case-control study of adult patients presenting to the WellSpan York Hospital Emergency Department (YHED) with signs and symptoms of esophageal food or foreign body impaction. Point of care ultrasound (POCUS) will then be performed by a trained emergency physician to collect ultrasound data, including the presence or absence of direct visualization food bolus/foreign body, as well as secondary markers of dilatation, such as maximal esophageal area. Investigators will also enroll an age/sex-matched control group of asymptomatic individuals to establish baseline esophageal measurements.

Patients will otherwise receive medical treatment per standard of care. Subsequent interventions will also be documented, including glucagon, carbonated beverages, and esophagogastroduodenoscopy (EGD). If patients remain in the ED and improve without need for EGD they will undergo repeat ultrasound. Chart review at 1 month will be performed to establish results of EGD including improvement, recurrence, or presence of pathologic abnormalities. The investigators aim to establish normal and abnormal parameters to aid in the diagnosis of esophageal food impactions to predict need for definitive EGD management.

03

Conditions studied

  • Esophageal Foreign Body
  • Esophageal Obstruction

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

This will be a case-control study of adult patients presenting to the WellSpan York Hospital Emergency Department (YHED) with signs and symptoms of esophageal food or foreign body impaction. We will also enroll an age/sex-matched control group of asymptomatic individuals to establish baseline esophageal measurements.

Eligibility criteria

Eligibility (CASES)

  • Inclusion criteria:

    1. Age ≥18 years
    2. Signs and symptoms of esophageal food bolus or foreign body
  • Exclusion criteria:

    1. Prior esophageal surgery
    2. History of head/neck cancer
    3. Incarcerated individuals
    4. Individuals unable to provide consent
    5. Clinical instability or airway compromise

Eligibility (CONTROLS)

  • Inclusion criteria:

    1. Age ≥18 years
    2. NO signs or symptoms of esophageal food bolus or foreign body
    3. Age/Sex match to previously enrolled case subject
  • Exclusion criteria:

    1. Prior esophageal surgery/dilation/pathology
    2. History of head/neck cancer
    3. Incarcerated individuals
    4. Individuals unable to provide consent
    5. Clinical instability or airway compromise
    6. Presentation involving any of the following symptoms:
  • Nausea/vomiting
  • Diarrhea
  • Abdominal pain
  • Chest pain
  • Shortness of breath
  • Dysphagia/odynophagia
  • Cough
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
30 participants (estimated)
Patient registry
No

Groups and cohorts

  • Esophageal foreign body/impaction (suspected)

    Diagnostic Test: Point of care ultrasound

  • Control (No symptoms of esophageal foreign body/impaction)

    Diagnostic Test: Point of care ultrasound

Interventions

  • Diagnostic testPoint of care ultrasound

    Point of care medical ultrasound machines will be used to sonographically visualize the esophagus and following sonographic data will be collected: * Presence/absence of suspected foreign body * Sonographic esophageal measurements (diameters, area) * Other relevant secondary sonographic findings

06

What researchers measure

Primary outcomes

  1. Presence or absence of esophageal foreign body/food impaction

    Presence of absence of esophageal foreign body/food impaction on esophagogastroduodenoscopy

    Time frame: Within 48 hours of index visit (Emergency department arrival to emergency department or hospital discharge)

Secondary outcomes

  1. Number/proportion of subjects experiencing resolution of symptoms with standard medical therapies

    Number/proportion of subjects experiencing resolution of symptoms with standard medical therapies, including glucagon and carbonated beverages

    Time frame: Within 48 hours of index visit (Emergency department arrival to emergency department or hospital discharge)

  2. Number/proportion of subjects requiring endoscopic intervention

    Number/proportion of subjects needing interventional procedures during esophagogastroduodenoscopy due to esophageal symptoms

    Time frame: Within 48 hours of index visit (Emergency department arrival to emergency department or hospital discharge)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2024 (actual). Primary completion is estimated for Dec 2026, 29 months after the start.

Of 28 observational studies under Airway Obstruction, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 28. This study's planned 29 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 5, 2024
First posted
Jul 18, 2024
StartActual
Jul 1, 2024
Primary completionEst.
Dec 31, 2026
CompletionEst.
Mar 1, 2027
Last update
Jun 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06507670
Lead sponsor
WellSpan Health
Responsible party
Brent Becker (Research Director - Department of Emergency Medicine, WellSpan Health) — Principal investigator
First posted
Jul 18, 2024
Start date
Jul 1, 2024
Primary completion
Dec 31, 2026 (estimated)
Completion
Mar 1, 2027 (estimated)
Last update
Jun 3, 2026

Study contacts

Kristen Oliff
Contact
koliff@wellspan.org
717-851-5075
Brent Becker, MD
Contact
bbecker2@wellspan.org
717-851-4819

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion